Archive for the ‘nanotechnology’ Category

CLG<<Sept 21 (Reuters) Shares of VeriChip Corp (CHIP.O: Quote, Profile, Research, Stock Buzz) tripled after the company said it had been granted an exclusive license to two patents, which will help it to develop implantable virus detection systems in humans.


The patents, held by VeriChip partner Receptors LLC, relate to biosensors that can detect the H1N1 and other viruses, and biological threats such as methicillin-resistant Staphylococcus aureus, VeriChip said in a statement.

The technology will combine with VeriChip’s implantable radio frequency identification devices to develop virus triage detection systems.

The triage system will provide multiple levels of identification — the first will identify the agent as virus or non-virus, the second level will classify the virus and alert the user to the presence of pandemic threat viruses and the third level will identify the precise pathogen, VeriChip said in a white paper published May 7, 2009.

Shares of VeriChip were up 186 percent at $3.28 Monday late afternoon trade on Nasdaq. They had touched a year high of $3.43 earlier in the session. (Reporting by Mansi Dutta in Bangalore; Editing by Mike Miller and Anil D’Silva)

Advertisements
BTC- Take your grain of salt. Tell any of your healthcare practioner friends who have been told to take the H1N1 vaccine as a condition of their employment to get a lawyer, contact the labor unions and organize a walk out. At least get them to find out what’s in it.
No matter what you believe about H1N1 today; if anyone in a position of authority even hints to the effect that you will be either incarcerated or let go from your job on the conditions of taking a H1N1 vaccine, go get a lawyer. Don’t wait.

World Net Daily..

Next step in H1N1 scare:
Microchip implants
Company developing under-the-skin devices to detect ‘bio-threats’

A Florida-based company that boasts selling the world’s first and only federally approved radio microchip for implanting in humans is now turning its development branch toward “emergency preparedness,” hoping to produce an implant that can automatically detect in its host’s bloodstream the presence of swine flu or other viruses deemed a “bio-threat.”

VeriChip Corporation currently sells a small, under-the-skin Radio Frequency Identification capsule, or RFID, that patients can opt to have implanted, containing a number computer-linked to their medical records, enabling doctors with a special reader to access the information even if the patient is unconscious or unidentified. The company boasts its microchip, roughly the size of a grain of rice, is the only such implant approved by the U.S. Food and Drug Administration.

But VeriChip has also turned its attention to other uses for the technology, including microchips that be used to tag and log human remains after a disaster and implants the company hopes will be able to warn if their host is infected with the H1N1 swine flu virus, the H5N1 bird flu virus or other pandemic agents deemed to be a “bio-threat.”

VeriChip is working with a Minnesota company, Receptors LLC, to develop the virus-detection technology.

“As we continue to build on our partnership with Receptors, which started with the development of a glucose-sensing RFID implantable microchip, we are moving beyond patient identification to sensors that can detect and identify illnesses and viruses such as influenza,” said Scott R. Silverman, chairman of VeriChip, in a statement. “This is an exciting next step for the future of our healthcare division.” :::MORE HERE:::